… We report 4-year follow-up results from ELEVATE-TN. … : 7.8% [9]) to the current report at a
follow-up of 4 years (30.7% and 11.2%, … With longer-term follow-up, the tolerability profile of the …

… To assess the effect of follow‐up programmes (follow‐up versus no follow‐up, follow‐up
strategies of varying intensity, and follow‐up in different healthcare settings) on overall survival …

… This epidemiologic study, based on a prospective follow-up, was carried out in our … those
lost to follow-up at D30. The infectious diseases unit was in charge of the outpatient follow-up …

… follow-up recommendations to patients and referring physicians. Recommendations for
follow-… Our aim was to review newly available evidence and update recommendations for follow-…

Background Acalabrutinib is a selective, covalent Bruton tyrosine-kinase inhibitor with activity
in chronic lymphocytic leukaemia. We compare the efficacy of acalabrutinib with or without …

Microbes drive most ecosystems and are modulated by viruses that impact their lifespan,
gene flow, and metabolic outputs. However, ecosystem-level impacts of viral community …

… , brand, or construct with a mean or median follow-up of greater than 15 years. We excluded
… six registries that had greater than 15 years of follow-up for total hip replacement at the time …

Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic …

… Chest CT plays a crucial role in the diagnosis and follow-up of patients with COVID-19 …
The purpose of this study was to evaluate pulmonary changes on 6-month follow-up chest …

Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the Western world
with an incidence of 4.2/100 000/year. The incidence increases to more than 30/100 000/year …